4//SEC Filing
ARBEL IRIT 4
Accession 0001104659-21-148750
CIK 0001137883other
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 8:02 PM ET
Size
6.0 KB
Accession
0001104659-21-148750
Insider Transaction Report
Form 4
ARBEL IRIT
Director
Transactions
- Award
Stock Option (right to buy)
2021-12-10+25,333→ 25,333 totalExercise: $0.75Exp: 2031-12-10→ Common Stock (25,333 underlying)
Footnotes (1)
- [F1]In connection with the Company's 2020 Annual Meeting of Stockholders, pursuant to the Company's Second Amended and Restated Director Compensation Plan, as amended, option vested and became exercisable in 12 consecutive, equal monthly installments commencing on December 11, 2020 until fully vested and exercisable on the 12 month anniversary of November 11, 2020, provided that the Reporting Person remained a member of the Board of Directors of the Issuer on each vesting date.
Documents
Issuer
BRAINSTORM CELL THERAPEUTICS INC.
CIK 0001137883
Entity typeother
Related Parties
1- filerCIK 0001245607
Filing Metadata
- Form type
- 4
- Filed
- Dec 9, 7:00 PM ET
- Accepted
- Dec 10, 8:02 PM ET
- Size
- 6.0 KB